病原體滅菌系統市場－全球產業規模、佔有率、趨勢、機會和預測，按類型、應用、產品、最終用戶、地區和競爭細分，2020 年至 2030 年

2024年，全球病原體去活化系統市場價值為7.1906億美元，預計在預測期內將呈現顯著成長，到2030年複合年成長率將達到8.00%。病原體是能夠引起人體嚴重感染和疾病的有害微生物。為了降低輸血過程中傳播感染的風險，人們採用了病原體去活化系統。該系統包含一系列旨在去活化或去除血液和血液製品（例如血漿、紅血球和血小板）中病原體的製程和技術。在為免疫系統較弱的患者輸血時，確保這些產品的安全性尤其重要，因為受污染的血液可能引發不良的免疫反應或導致進一步的併發症。

病原體去活化的主要目標是透過最大限度地降低輸血傳播感染的風險來增強血液供應的安全性。為了實現這一目標，人們採用了多種先進方法。其中，紫外線 (UV) 和光化學處理被廣泛應用。這些技術透過破壞病原體的核酸（DNA 或 RNA）來發揮作用，從而有效地阻止其複製和造成危害。光化學處理通常涉及在血液製品中添加一種感光化合物，這種化合物在暴露於紫外線下時會與病原體的遺傳物質相互作用，使其失效。除了基於紫外線的技術外，過濾方法也在病原體去活化中發揮關鍵作用。這些方法包括讓血液通過專門設計的細菌過濾器，其孔徑足夠小，可以在物理上阻擋病原體，同時允許血液的主要成分通過。這些方法共同作用，有助於確保輸血盡可能安全且無病原體。透過實施病原體去活化技術，醫療保健系統可以顯著降低輸血過程中疾病傳播的風險，從而保障患者健康並改善預後，尤其是對於免疫功能低下的患者。

關鍵市場促進因素

提高對感染控制的認知與重視

主要市場挑戰

技術複雜性與成本

主要市場趨勢

先進技術與創新

目錄

第 1 章：產品概述

第2章：研究方法

第3章：執行摘要

第4章：顧客之聲

第5章：全球病原體去活化系統市場展望

• 市場規模和預測
  • 按價值
• 市場佔有率和預測
  • 依類型（血小板病原體減少、血漿病原體減少）
  • 依應用（病毒、真菌、細菌）
  • 按產品（自動化、半自動化）
  • 按最終使用者（醫院和診所、門診護理中心、血庫、其他）
  • 按地區（北美、歐洲、亞太、南美、中東和非洲）
  • 按公司分類（2024）
• 市場地圖

第6章：北美病原體去活化系統市場展望

• 市場規模和預測
• 市場佔有率和預測
• 北美：國家分析
  • 美國
  • 加拿大
  • 墨西哥

第7章：歐洲病原體去活化系統市場展望

• 市場規模和預測
• 市場佔有率和預測
• 歐洲：國家分析
  • 法國
  • 德國
  • 英國
  • 義大利
  • 西班牙

第8章：亞太病原體去活化系統市場展望

• 市場規模和預測
• 市場佔有率和預測
• 亞太地區：國家分析
  • 中國
  • 印度
  • 日本
  • 韓國
  • 澳洲

第9章：南美洲病原體去活化系統市場展望

• 市場規模和預測
• 市場佔有率和預測
• 南美洲：國家分析
  • 巴西
  • 阿根廷
  • 哥倫比亞

第10章：中東和非洲病原體去活化系統市場展望

• 市場規模和預測
• 市場佔有率和預測
• MEA：國家分析
  • 南非
  • 沙烏地阿拉伯
  • 阿拉伯聯合大公國

第 11 章：市場動態

• 驅動程式
• 挑戰

第 12 章：市場趨勢與發展

• 近期發展
• 併購
• 產品發布

第 13 章：全球病原體減少系統市場：SWOT 分析

第 14 章：波特五力分析

• 產業競爭
• 新進入者的潛力
• 供應商的力量
• 顧客的力量
• 替代產品的威脅

第 15 章：競爭格局

第 15 章：1 Terumo BCT, Inc.

第 15 章：2 Macopharma SA。

第 15 章：3 Cerus 公司。

第 15 章：4 AngioDynamics, Inc.

第 15 章：5 Octapharma AG。

第 16 章：策略建議

第17章調查會社について,免責事項

Global Pathogen Reduction Systems Market was valued at USD 719.06 Million in 2024 and is anticipated to project impressive growth in the forecast period with a CAGR of 8.00% through 2030. Pathogens are harmful microorganisms capable of causing serious infections and diseases in the human body. To mitigate the risk of transmitting infections during transfusions, a pathogen reduction system is utilized. This system includes a range of processes and technologies designed to inactivate or remove pathogens from blood and blood products such as plasma, red blood cells, and platelets. Ensuring the safety of these products is especially critical when transfusing patients with weakened immune systems, as contaminated blood could trigger adverse immune responses or lead to further complications.

The main goal of pathogen reduction is to enhance the safety of the blood supply by minimizing the risk of transfusion-transmitted infections. Several advanced methods are employed to achieve this. Among them, ultraviolet (UV) light and photochemical treatments are widely used. These techniques work by damaging the nucleic acids (DNA or RNA) of pathogens, effectively preventing them from replicating and causing harm. Photochemical treatments often involve adding a photosensitive compound to the blood product, which, when exposed to UV light, interacts with the pathogen's genetic material, rendering it non-functional. In addition to UV-based technologies, filtration methods also play a key role in pathogen reduction. These involve passing blood through specialized bacterial filters designed with pore sizes small enough to physically block pathogens while allowing essential blood components to pass through. Together, these methods help ensure that transfused blood is as safe and pathogen-free as possible. By implementing pathogen reduction technologies, healthcare systems can significantly reduce the risk of disease transmission during transfusion, thereby safeguarding patient health and improving outcomes, especially for immunocompromised individuals.

Key Market Drivers

Increasing Awareness and Emphasis on Infection Control

Increasing awareness and emphasis on infection control have a significant influence on the growth of the global pathogen reduction systems market. As awareness about the risks and consequences of infections grows, there is a higher demand for effective infection control solutions. For instance, on June 2025, Cerus Corporation (NASDAQ:CERS) participated in the Goldman Sachs 46th Annual Global Healthcare Conference. CEO Obi Greenman highlighted the company's strategic focus on pathogen reduction technologies and the growing adoption of its INTERCEPT blood system. Despite a solid financial foundation and market leadership, Cerus continues to navigate challenges related to expanding market penetration and securing regulatory approvals. Pathogen reduction systems are essential tools in combating the spread of infections in various settings, including healthcare facilities, food processing industries, and public spaces. The emphasis on infection control drives the adoption of these systems, resulting in market growth. Governments and regulatory bodies worldwide have implemented stringent standards and guidelines related to infection control. Compliance with these regulations necessitates the use of pathogen reduction systems in various industries. The awareness of these requirements drives organizations to invest in and implement these systems to ensure compliance and maintain public health and safety. HAIs pose a significant risk to patients, healthcare providers, and the healthcare system as a whole. Increasing awareness of the prevalence and impact of HAIs has led to a greater emphasis on infection control in healthcare settings. Pathogen reduction systems play a crucial role in minimizing the risk of HAIs by eliminating or reducing the presence of pathogens. The focus on infection control in healthcare drives the demand for these systems. Outbreaks of infectious diseases, such as the COVID-19 pandemic, have highlighted the critical importance of infection control and prevention. Governments, healthcare organizations, and other institutions are now prioritizing the preparedness and response to such outbreaks. Pathogen reduction systems are considered essential tools in mitigating the spread of diseases during outbreaks, resulting in increased adoption and market growth. Consumers are becoming more conscious of the risks associated with infections, especially in the context of food safety and public spaces. They expect businesses and establishments to prioritize infection control measures and provide safe environments. This consumer awareness and expectation drive the demand for pathogen reduction systems in industries such as food processing, hospitality, and public facilities. Increased awareness of the importance of infection control has led to collaborative efforts among governments, healthcare organizations, and educational institutions to educate the public about best practices. These initiatives raise awareness about the role of pathogen reduction systems and their effectiveness in preventing the spread of infections. As a result, there is greater acceptance and adoption of these systems, contributing to market growth.

Key Market Challenges

Technological Complexity and Cost

Developing and implementing effective pathogen reduction technologies can be complex and costly. The research, development, and testing of these systems require significant resources, which can impact their affordability and accessibility, especially for small-scale producers. Adhering to strict regulatory standards and guidelines is crucial for pathogen reduction systems, particularly in the food industry. Meeting and maintaining these regulations can be challenging due to evolving standards and variations in requirements across different regions and countries. Introducing new pathogen reduction methods can sometimes face resistance from consumers who might be concerned about the impact of these processes on the sensory qualities, nutritional value, or overall safety of the products.

Key Market Trends

Advanced Technologies and Innovation

The pathogen reduction systems market is likely to see continuous advancements in technologies such as nanotechnology, advanced filtration, and new chemical treatments. These innovations could lead to more efficient and targeted pathogen reduction methods. The integration of Internet of Things (IoT) technology and smart sensors could enable real-time monitoring, data collection, and control of pathogen reduction processes. This could enhance system efficiency, reduce waste, and improve response times to potential issues. Pathogen reduction systems could be integrated more seamlessly into global supply chains, ensuring the safety of products as they move across various stages of production, distribution, and consumption.

Key Market Players

• Terumo BCT, Inc.
• Macopharma SA.
• Cerus Corporation.
• AngioDynamics, Inc.
• Octapharma AG.

Report Scope:

In this report, the Global Pathogen Reduction Systems Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Pathogen Reduction Systems Market, By Type:

• Platelet Pathogen Reduction
• Plasma Pathogen Reduction

Pathogen Reduction Systems Market, By Application:

• Viruses
• Fungi
• Bacteria

Pathogen Reduction Systems Market, By Product:

• Automated
• Semi-Automated

Pathogen Reduction Systems Market, By End User:

• Hospitals & Clinics
• Ambulatory Care centers
• Blood Banks
• Others

Pathogen Reduction Systems Market, By Region:

• North America
  • United States
  • Canada
  • Mexico
• Europe
  • France
  • Germany
  • United Kingdom
  • Italy
  • Spain
• Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Australia
• South America
  • Brazil
  • Argentina
  • Colombia
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Pathogen Reduction Systems Market.

Available Customizations:

Global Pathogen Reduction Systems market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validation
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Pathogen Reduction Systems Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Type (Platelet Pathogen Reduction, Plasma Pathogen Reduction)
  • 5.2.2. By Application (Viruses, Fungi, Bacteria)
  • 5.2.3. By Product (Automated, Semi-Automated)
  • 5.2.4. By End User (Hospitals & Clinics, Ambulatory Care centers, Blood Banks, Others)
  • 5.2.5. By Region (North America, Europe, Asia Pacific, South America, Middle East & Africa)
  • 5.2.6. By Company (2024)
• 5.3. Market Map

6. North America Pathogen Reduction Systems Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Type (Platelet Pathogen Reduction, Plasma Pathogen Reduction)
  • 6.2.2. By Application (Viruses, Fungi, Bacteria)
  • 6.2.3. By Product (Automated, Semi-Automated)
  • 6.2.4. By End User (Hospitals & Clinics, Ambulatory Care centers, Blood Banks, Others)
  • 6.2.5. By Country
• 6.3. North America: Country Analysis
  • 6.3.1. United States Pathogen Reduction Systems Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Type
      • 6.3.1.2.2. By Application
      • 6.3.1.2.3. By Product
      • 6.3.1.2.4. By End User
  • 6.3.2. Canada Pathogen Reduction Systems Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Type
      • 6.3.2.2.2. By Application
      • 6.3.2.2.3. By Product
      • 6.3.2.2.4. By End User
  • 6.3.3. Mexico Pathogen Reduction Systems Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Type
      • 6.3.3.2.2. By Application
      • 6.3.3.2.3. By Product
      • 6.3.3.2.4. By End User

7. Europe Pathogen Reduction Systems Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Type (Platelet Pathogen Reduction, Plasma Pathogen Reduction)
  • 7.2.2. By Application (Viruses, Fungi, Bacteria)
  • 7.2.3. By Product (Automated, Semi-Automated)
  • 7.2.4. By End User (Hospitals & Clinics, Ambulatory Care centers, Blood Banks, Others)
  • 7.2.5. By Country
• 7.3. Europe: Country Analysis
  • 7.3.1. France Pathogen Reduction Systems Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Type
      • 7.3.1.2.2. By Application
      • 7.3.1.2.3. By Product
      • 7.3.1.2.4. By End User
  • 7.3.2. Germany Pathogen Reduction Systems Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Type
      • 7.3.2.2.2. By Application
      • 7.3.2.2.3. By Product
      • 7.3.2.2.4. By End User
  • 7.3.3. United Kingdom Pathogen Reduction Systems Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Type
      • 7.3.3.2.2. By Application
      • 7.3.3.2.3. By Product
      • 7.3.3.2.4. By End User
  • 7.3.4. Italy Pathogen Reduction Systems Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By Type
      • 7.3.4.2.2. By Application
      • 7.3.4.2.3. By Product
      • 7.3.4.2.4. By End User
  • 7.3.5. Spain Pathogen Reduction Systems Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By Type
      • 7.3.5.2.2. By Application
      • 7.3.5.2.3. By Product
      • 7.3.5.2.4. By End User

8. Asia-Pacific Pathogen Reduction Systems Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Type (Platelet Pathogen Reduction, Plasma Pathogen Reduction)
  • 8.2.2. By Application (Viruses, Fungi, Bacteria)
  • 8.2.3. By Product (Automated, Semi-Automated)
  • 8.2.4. By End User (Hospitals & Clinics, Ambulatory Care centers, Blood Banks, Others)
  • 8.2.5. By Country
• 8.3. Asia-Pacific: Country Analysis
  • 8.3.1. China Pathogen Reduction Systems Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Type
      • 8.3.1.2.2. By Application
      • 8.3.1.2.3. By Product
      • 8.3.1.2.4. By End User
  • 8.3.2. India Pathogen Reduction Systems Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Type
      • 8.3.2.2.2. By Application
      • 8.3.2.2.3. By Product
      • 8.3.2.2.4. By End User
  • 8.3.3. Japan Pathogen Reduction Systems Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Type
      • 8.3.3.2.2. By Application
      • 8.3.3.2.3. By Product
      • 8.3.3.2.4. By End User
  • 8.3.4. South Korea Pathogen Reduction Systems Market Outlook
    • 8.3.4.1. Market Size & Forecast
      • 8.3.4.1.1. By Value
    • 8.3.4.2. Market Share & Forecast
      • 8.3.4.2.1. By Type
      • 8.3.4.2.2. By Application
      • 8.3.4.2.3. By Product
      • 8.3.4.2.4. By End User
  • 8.3.5. Australia Pathogen Reduction Systems Market Outlook
    • 8.3.5.1. Market Size & Forecast
      • 8.3.5.1.1. By Value
    • 8.3.5.2. Market Share & Forecast
      • 8.3.5.2.1. By Type
      • 8.3.5.2.2. By Application
      • 8.3.5.2.3. By Product
      • 8.3.5.2.4. By End User

9. South America Pathogen Reduction Systems Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Type (Platelet Pathogen Reduction, Plasma Pathogen Reduction)
  • 9.2.2. By Application (Viruses, Fungi, Bacteria)
  • 9.2.3. By Product (Automated, Semi-Automated)
  • 9.2.4. By End User (Hospitals & Clinics, Ambulatory Care centers, Blood Banks, Others)
  • 9.2.5. By Country
• 9.3. South America: Country Analysis
  • 9.3.1. Brazil Pathogen Reduction Systems Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Type
      • 9.3.1.2.2. By Application
      • 9.3.1.2.3. By Product
      • 9.3.1.2.4. By End User
  • 9.3.2. Argentina Pathogen Reduction Systems Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Type
      • 9.3.2.2.2. By Application
      • 9.3.2.2.3. By Product
      • 9.3.2.2.4. By End User
  • 9.3.3. Colombia Pathogen Reduction Systems Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Type
      • 9.3.3.2.2. By Application
      • 9.3.3.2.3. By Product
      • 9.3.3.2.4. By End User

10. Middle East and Africa Pathogen Reduction Systems Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Type (Platelet Pathogen Reduction, Plasma Pathogen Reduction)
  • 10.2.2. By Application (Viruses, Fungi, Bacteria)
  • 10.2.3. By Product (Automated, Semi-Automated)
  • 10.2.4. By End User (Hospitals & Clinics, Ambulatory Care centers, Blood Banks, Others)
  • 10.2.5. By Country
• 10.3. MEA: Country Analysis
  • 10.3.1. South Africa Pathogen Reduction Systems Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Type
      • 10.3.1.2.2. By Application
      • 10.3.1.2.3. By Product
      • 10.3.1.2.4. By End User
  • 10.3.2. Saudi Arabia Pathogen Reduction Systems Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Type
      • 10.3.2.2.2. By Application
      • 10.3.2.2.3. By Product
      • 10.3.2.2.4. By End User
  • 10.3.3. UAE Pathogen Reduction Systems Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Type
      • 10.3.3.2.2. By Application
      • 10.3.3.2.3. By Product
      • 10.3.3.2.4. By End User

11. Market Dynamics

• 11.1. Drivers
• 11.2. Challenges

12. Market Trends & Developments

• 12.1. Recent Development
• 12.2. Mergers & Acquisitions
• 12.3. Product Launches

13. Global Pathogen Reduction Systems Market: SWOT Analysis

14. Porter's Five Forces Analysis

• 14.1. Competition in the Industry
• 14.2. Potential of New Entrants
• 14.3. Power of Suppliers
• 14.4. Power of Customers
• 14.5. Threat of Substitute Products

15. Competitive Landscape

15.1 Terumo BCT, Inc.

15.2 Macopharma SA.

15.3 Cerus Corporation.

15.4 AngioDynamics, Inc.

15.5 Octapharma AG.

16. Strategic Recommendations

17. About Us & Disclaimer